Spravato Esketamine: What we know so far….

Spravato Esketamine: What we know so far….

The FDA approved a new nasal spray medication for treatment-resistant depression called Spravato, trade name for Esketamine on March 5, 2019. We’ve had many inquiries about the medication at our practice and I thought it would be beneficial to all of you to share the...